Unspecified GLP-1
Sold by Maven Clinic · Oral tablet · every unspecified glp-1 record
Price
| Term | Published rate | Charged today |
|---|---|---|
| Foundayo Pill, self-pay Price conditions have not been established; the quoted figure is not a verified recurring rate. “Foundayo® Pill Oral GLP-1 pill for chronic weight management to help regulate appetite and food intake—taken anytime, no food or water restrictions $149 /mo self-pay | Starting from $25 /mo with insurance” | $149Published figure | Charged todayNot verified |
| Foundayo Pill, with insurance (starting from) Price conditions have not been established; the quoted figure is not a verified recurring rate. Insurance coverage and applicable plan terms required; individual copays may vary. “$149 /mo self-pay | Starting from $25 /mo with insurance” | $25Published figure | Charged todayNot verified |
Price sources
- Foundayo Pill, self-pay · mavenclinic.com — read September 2026
- Foundayo Pill, with insurance (starting from) · mavenclinic.com — read September 2026
We earn nothing from this link. It opens Maven Clinic's website without a paid referral.
History
Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.
- September 2026 — Entry added to the register
Sourcing and terms
| Pharmacy | Not disclosed |
|---|---|
| States | Not disclosed |
| Prescriber | Both |
| Cancellation | Cancel through account settings or consumer support at least 48 hours before the next billing processing date. Access continues through the paid period, with no prorated refund. A full refund may be available within three business days of enrollment if no services have been received. Ineligibility refunds follow the checkout policy and may exclude clinical review already performed. |
| Membership | Not disclosed |
| Consult fee | Not disclosed |
Recorded from mavenclinic.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2026 — Company confirmed via own site (title 'Maven Clinic - The next generation of care for women and families', footer '© 2026 Maven Clinic Co.'). This is exactly the membership-vs-medication trap the brief warns about: the 'glp-1 care membership' is $150/month (first month discounted to $39 per the pricing section: 'glp-1 care membership $150 $39 / first month Then $150 /month') and covers clinician visits, two specialist consultations, dose adjustments, and side-effect management -- it explicitly does NOT include the medication ('Medication costs separate'). Medication is billed separately by the pharmacy at self-pay or insurance rates listed per product; both self-pay and insurance ('starting from') figures are recorded as separate price entries per drug/form, labeled accordingly, per the insurance-vs-cash-price rule. 'Foundayo' is described only as 'Oral GLP-1 pill' with no active ingredient named on any page checked, so it was classified as unspecified GLP-1 rather than assumed to be semaglutide. The Zepbound Pen self-pay price is printed as an open-ended '$1,000+/mo' (not a fixed number); recorded perMonth as the floor value with the exact quote showing it is open-ended. No explicit state-availability list or cancellation policy was found on the marketing pages checked (the GLP-1 safety-information legal page is JavaScript-rendered and returned no text).
- 2. October 2026 — Maven’s current program combines metabolic and hormone care. It lists brand-name medications only and advertises broad starting prices that depend on medication, dose and insurance eligibility. The page does not reconfirm the older drug-specific quotes or $150 membership amount. Included first nutrition and strength-coaching visits do not establish that the prescribing consultation is free.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.